Skip to main content
Top

20-09-2024 | Heart Failure | Editor's Choice | News

ESC 2024

Meta-analysis indicates MRAs benefit HF patients across ejection fraction phenotypes

Author: Laura Cowen

medwireNews: Mineralocorticoid receptor antagonists (MRAs) reduce the risk for heart failure (HF) hospitalization or cardiovascular death in patients with HF, regardless of their ejection fraction phenotype, suggests a patient-level meta-analysis of four randomized controlled trials.

Related topics

Related content

05-09-2024 | Heart Failure | Expert Interview | Article

Researcher comment on MRAs in heart failure

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now